> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# PhRMA Adds Diversity to Clinical Trial Principles
- URL: https://www.fdaweb.com/phrma-adds-diversity-to-clinical-trial-principles/
- Published: 2020-11-17T12:00:00.000Z
- Updated: 2026-09-14T16:36:43.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5148100

Pharmaceutical Research and Manufacturers of America (PhRMA) has added a new chapter, “Enhancing Diversity in Clinical Trial Participation,” to its *Principles on Conduct of Clinical Trials and Communication of Clinical Trial Results*. A PhRMA [statement](https://www.phrma.org/en/Codes-and-guidelines/PhRMA-Principles-on-Conduct-of-Clinical-Trials?ref=fdaweb.com) says the revised principles take effect 4/14/21.

With the revision, the statement says, PhRMA member companies commit to continuing to work with patients, patient advocacy groups, regulatory authorities, healthcare practitioners, academics, and policymakers to “define the systematic and impactful approaches that we will take to enhance the diversity of clinical trial participants and help reduce healthcare disparities.”